Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study

INTRODUCTION: Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism by which this reduction in mortality is achieved is still not clearly defined. The aim of the present study was to evaluate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: de Pont, Anne-Cornélie JM, Bakhtiari, Kamran, Hutten, Barbara A, de Jonge, Evert, Vroom, Margreeth B, Meijers, Joost CM, Büller, Harry R, Levi, Marcel
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2005
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297612/
https://ncbi.nlm.nih.gov/pubmed/16277710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc3774
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars